Envestnet Asset Management
BCAB icon

Envestnet Asset Management’s BioAtla BCAB Stock Holding History

Envestnet Asset Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-431
Closed -$74.2K – 4175
2024
Q1 		$74.2K Buy
431
+71
+20% +$8.82K ﹤0.01% 4083
2023
Q4 		$44.2K Buy
+360
New +$31.2K ﹤0.01% 3991

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Envestnet Asset Management's BCAB Position: Q2 2024 in Review

Envestnet Asset Management sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 431 shares — an estimated $74.2K sold.

Envestnet Asset Management first reported a position in BCAB in Q4 2023 and held it in 2 quarters. The position peaked at $74.2K in Q1 2024. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • Envestnet Asset Management reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 431 BioAtla shares in Q2 2024, an estimated $74.2K.
  • Envestnet Asset Management first reported a position in BioAtla in Q4 2023 and held it in 2 quarters.
  • Envestnet Asset Management's BioAtla position peaked at $74.2K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Envestnet Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.